Stock listing

Immatics N.v.

Selected listing: IMTX · NASDAQ · USD · US

Immatics N.v. (NASDAQ:IMTX), Health Technology. Latest release Aug 25, 2026: Immatics Announces $150 Million Underwritten Offering.

IMTX:NASDAQUSDUSUpdated October 2, 2026

Ticker: NASDAQ:IMTX
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: NASDAQ
Currency: USD

About Immatics N.v.

Immatics N.V. is a public company traded under the ticker IMTX in the American market. Immatics focuses on developing innovative cancer immunotherapies.

Latest news from Immatics N.v.

Immatics Announces $150 Million Underwritten Offering

August 25, 2026

Immatics N : Announces Second Quarter 2026 Financial Results and Business Update

August 18, 2026

Immatics Announces Second Quarter 2026 Financial Results and Business Update

August 18, 2026

Immunomic Therapeutics Announces First Patient Dosed in Phase 1 Trial of Cancer Vaccine Candidate ITI-5000

July 20, 2026

Immatics Announces Upcoming Presentations Across Its PRAME Franchise at ESMO Congress 2026

July 17, 2026

All Immatics N.v. news →

Research Immatics N.v.

Immatics N.v. company profile

View the public company page for Immatics N.v. on 6ix.

Immatics N.v. news

Read company news and market updates connected to Immatics N.v..

Immatics N.v. investor events

Find investor webinars, events, and replay context for Immatics N.v..